MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2021 » Epidemiology

Meeting: MDS Virtual Congress 2021

Application of the updated MDS criteria for prodromal Parkinson’s disease to a population-based 10-year study

K. Marini, K. Seppi, L. Tschiderer, S. Kiechl, H. Stockner, P. Willeit, J. Willeit, A. Djamshidian, G. Rungger, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

Body mass index and incidence of Parkinson’s disease in French women from the E3N cohort study

B. Portugal, F. Artaud, C. Domenighetti, E. Roze, I. Dagaey, M. Canonico, A. Elbaz (Villejuif, France)

Characteristics and outcomes of Parkinson’s disease individuals hospitalized with COVID-19 in a New York City hospital system

L. Nwabuobi, C. Zhang, C. Henchcliffe, H. Shah, H. Sarva, A. Lee, H. Kamel (New York, USA)

Clinical and Economic Outcomes Associated with Dysphagia in Hospitalized Patients with Parkinson’s Disease

D. Di Luca, E. Mcarthur, A. Willis, R. Martino, C. Marras (Toronto, Canada)

Clinical epidemiology of movement disorders in Douala General Hospital, Cameroon: A two years retrospective study

D. Gams Massi, AM. Magnerou, G. Tchumno Mayoue, EA. Babe, NY. Mapoure (Douala, Cameroon)

Depression in Patients with Parkinson’s disease among Tomsk population

M. Nikitina, N. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

Diagnostic accuracy in an incidence cohort of Parkinson’s disease

B. Brownlee, C. Counsell, A. Macleod (Aberdeen, United Kingdom)

Early-onset Dementia with Lewy Bodies and Parkinson’s Disease Dementia: A Population-based Study (2010-2015).

E. Camerucci, C. Stang, M. Hajeb, P. Turcano, A. Mullan, D. Jones, J. Graff-Radford, O. Ross, J. Bower, B. Boeve, R. Savica (Rochester, USA)

Emerging parkinsonism in the PREDICT-PD cohort after 6-years of follow-up

C. Simonet, A. Gill, J. Bestwick, A. Lees, G. Giovannoni, A. Schrag, A. Noyce (London, United Kingdom)

Epidemiology of Huntington Disease in Tatarstan republic, Russia. One-moment investigation

Z. Zalyalova, S. Munasipova, D. Khasanova (Kazan, Russian Federation)

Is past use of statins associated with lower incidence of Parkinson’s disease?

TTH. Nguyen, A. Fournier, F. Artaud, E. Courtois, S. Escolano, P. Tubert-Bitter, MC. Boutron, G. Severi, E. Roze, I. Degaey, M. Canonico, I. Ahmed, A. Thiébaut, A. Elbaz (Villejuif, France)

Is the association between cigarette smoking and Parkinson disease causal? A Mendelian Randomization study.

C. Domenighetti, PE. Sugier, A. Ashokkumar Sreelatha, C. Schulte, S. Grover, O. Mohamed, B. Portugal, P. May, D. Bobbili, M. Radivojkov-Blagojevic, P. Lichtner, R. Krüger, T. Gasser, M. Sharma, A. Elbaz (Villejuif Cedex, France)

Longitudinal healthcare utilization and costs in Parkinson disease : from pre-diagnosis to 9 years

S. Neo, E. Soh, A. Wong, W. Li, HL. Ng, KY. Tay, WL. Au, L. Tan (Singapore, Singapore)

Methods for addressing missing covariate data in left truncated samples with application to Parkinson’s disease research

H. Richardson, S. Xie (Philadelphia, USA)

Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area

R. Patel, G. Stebbins, B. Barton (Chicago, USA)

Mortality of people with Parkinson’s disease in a large population-based cohort study. Time trends and relationship to disease progression.

O. Okunoye, L. Horsfall, L. Marston, K. Walters, A. Schrag (London, United Kingdom)

Optimizing an Electronic Health Records (EHR)-based Algorithm for Parkinson’s Disease Case Ascertainment

A. Duarte Folle, L. Uhr, F. Agosta, T. Chang, C. Baddley, B. Ritz, C. Tanner, A. Wu, A. Wilson (Los Angeles, USA)

Overview of the population of patients with advanced Parkinson’s disease (aPD) initiating therapy with levodopa-carbidopa intestinal gel (LCIG): POMPE-PARK study on French health insurance data (2013-2017)

JP. Azulay, D. Grabli, S. Benard, N. Kabore, MS. Behier (Marseille, France)

Parkinson’s Disease Clinical Progression in Latino Patients

A. Duarte Folle, C. Kusters, K. Paul, B. Ritz, M. Flores, J. Bronstein, A. Keener (Los Angeles, USA)

Patient-Reported Impact of Standard-of-Care: Change in Symptoms Following Dopamine Initiation and Deep Brain Stimulation

L. Mischley, C. Weaver, J. Farahnik, Y. Chien (Kenmore, USA)

Patterns and determinants of healthcare utilization among people with Parkinson’s disease: A population based analysis in Ontario, Canada

E. Crighton, A. Ouédraogo, M. Sawada, T. Mestre (Ottawa, Canada)

Post-Traumatic Stress Disorder and risk of Parkinson’s Disease– 20 Years Follow-up real world data analysis

Y. Barer, G. Chodick, T. Gurevich (Tel Aviv, Israel)

Prevalence of advanced Parkinson’s disease in Thai patients with Parkinson’s disease using The Consensus on the Definition of Advance Parkinson’s disease (CEPA Study): A single-center study

K. Thanapermpool, J. Srikajon, Y. Pitakpatapee, W. Saengphatrachai, T. Sangpeamsook, T. Wangthumrong, A. Pisarnpong, P. Srivanitchapoom (Bangkok, Thailand)

Prevalence of Essential Tremors in Rural Gujarat, India

A. Chin, S. Arora, S. Raithata, D. Desai, U. Shah, A. Deb, S. Desai (Worcester, USA)

PREVALENCE OF MOVEMENT DISORDERS AT A TERTIARY HEALTH CARE CENTRE IN ABUJA, NIGERIA

N. Obianozie, G. Onwuegbuzie, P. Alabi, F. Abdulai (Gwagwalada, Nigeria)

Prevalence of Parkinsonism and Parkinson Disease in urban and rural populations in Latin America.

J. Llibre-Guerra, M. Prina, A. Sosa, D. Acosta, I. Jimenez-Velasquez, M. Guerra, A. Salas, A. Rodriguez-Salgado, J. Llibre-Guerra, G. Peters, I. Acosta, J. Juncos, J. Llibre-Rodriguez (La Habana, Cuba)

Racial and ethnic differences in patients with Parkinson’s Disease across Parkinson’s Disease Centers of Excellence

D. Di Luca, S. Luo, T. Davis, A. Ramirez-Zamora, M. Rafferty, N. Dahodwala, C. Marras (Toronto, Canada)

Reproductive factors and risk of Parkinson’s disease in women: preliminary results from the French prospective cohort E3N.

G. Pesce, F. Artaud, E. Roze, I. Degaey, A. Fournier, MC. Boutron-Ruault, A. Elbaz, M. Canonico (Villejuif, France)

The COVID-19 Pandemic Impact on Advanced Parkinson’s Disease in the US

D. Oleske, S. Talapala, P. Kukreja, M. Facheris, R. Dorsey, S. Dey, A. Isherwood (North Chicago, USA)

The prevalence and types of postural deformities in Thai patients with Parkinson’s disease: A single-center study

M. Vichutavate, P. Srivanitchapoom (Bangkok, Thailand)

« View all sessions from the MDS Virtual Congress 2021.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley